{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Recurrent+Intracranial+Neoplasm&page=2", "query": { "condition": "Recurrent Intracranial Neoplasm", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Recurrent+Intracranial+Neoplasm&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-23T21:01:26.393Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00589784", "title": "Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "CNS Cancer", "Meningioma", "Intracranial Hemangiopericytoma", "Hemangioblastoma", "Neurofibromatosis" ], "interventions": [ { "name": "Sunitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2007-10", "completion_date": "2014-10", "has_results": true, "last_update_posted_date": "2016-01-25", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 6, "location_summary": "Boston, Massachusetts • Basking Ridge, New Jersey • Commack, New York + 3 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00589784" }, { "nct_id": "NCT00047320", "title": "Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Brain Tumor", "Central Nervous System Tumors", "Childhood Germ Cell Tumor" ], "interventions": [ { "name": "carboplatin", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "thiotepa", "type": "DRUG" }, { "name": "adjuvant therapy", "type": "PROCEDURE" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "neoadjuvant therapy", "type": "PROCEDURE" }, { "name": "peripheral blood stem cell transplantation", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "24 Years", "sex": "ALL", "summary": "3 Years to 24 Years" }, "enrollment_count": 104, "start_date": "2004-01", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2018-02-14", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 90, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 79 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00047320" }, { "nct_id": "NCT02722512", "title": "Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Glioblastoma Multiforme", "Astrocytoma, Grade III", "Anaplastic Ependymoma", "Clear Cell Ependymoma", "Ependymoma" ], "interventions": [ { "name": "Heat Shock Protein Peptide Complex-96 (HSPPC-96)", "type": "BIOLOGICAL" }, { "name": "Tumor Resection", "type": "PROCEDURE" }, { "name": "Radiation", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "RADIATION" ], "sponsor": "Ann & Robert H Lurie Children's Hospital of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "3 Years to 21 Years" }, "enrollment_count": 10, "start_date": "2016-07", "completion_date": "2019-11-13", "has_results": false, "last_update_posted_date": "2025-02-18", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02722512" }, { "nct_id": "NCT00777686", "title": "Measuring Non-Enhancing Glioblastoma Progression", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Brain Tumor", "Glioblastoma" ], "interventions": [ { "name": "MRI/MRS Scan", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2008-08", "completion_date": "2011-03", "has_results": false, "last_update_posted_date": "2012-03-30", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00777686" }, { "nct_id": "NCT04427384", "title": "Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Brain Tumor, Recurrent", "Brain Tumor", "Brain Tumor, Primary", "Brain Tumor - Metastatic", "Brain Tumor, Adult: Glioblastoma", "Brain Tumor, Adult Meningioma" ], "interventions": [ { "name": "GammaTile", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "GT Medical Technologies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 600, "start_date": "2020-09-11", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 53, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Castro Valley, California + 45 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Castro Valley", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Laguna Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04427384" }, { "nct_id": "NCT01270724", "title": "Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "CNS Germ Cell Tumor" ], "interventions": [ { "name": "Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nationwide Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 10, "start_date": "2010-08", "completion_date": "2019-12-09", "has_results": true, "last_update_posted_date": "2025-10-27", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 5, "location_summary": "Phoenix, Arizona • Los Angeles, California • New York, New York + 1 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01270724" }, { "nct_id": "NCT07132190", "title": "Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Brain Metastases, Adult", "Brain Tumor - Metastatic", "Brain Metastases From Non-small Cell Lung Cancer (NSCLC)", "Brain Metastases From Extra-cranial Solid Tumors" ], "interventions": [ { "name": "Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Ayal A. Aizer, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2025-12-30", "completion_date": "2029-09", "has_results": false, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07132190" }, { "nct_id": "NCT03539731", "title": "[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subject", "Intracranial Neoplasm", "Glioblastoma" ], "interventions": [ { "name": "Fluorine F 18 DASA-23", "type": "DRUG" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Guido A. Davidzon, MD, SM", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2018-04-23", "completion_date": "2022-12-31", "has_results": false, "last_update_posted_date": "2024-08-12", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03539731" }, { "nct_id": "NCT00021229", "title": "Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Brain and Central Nervous System Tumors" ], "interventions": [ { "name": "imatinib mesylate", "type": "DRUG" }, { "name": "local irradiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "3 Years to 21 Years" }, "enrollment_count": 85, "start_date": "2001-05", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2014-07-31", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 10, "location_summary": "San Francisco, California • Washington D.C., District of Columbia • Chicago, Illinois + 7 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00021229" }, { "nct_id": "NCT04044937", "title": "Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Intracranial Neoplasm", "Low Grade Glioma", "Recurrent Glioblastoma", "Recurrent World Health Organization (WHO) Grade II Glioma", "Recurrent WHO Grade III Glioma" ], "interventions": [ { "name": "F-18 Fluoroethyltyrosine (FET)", "type": "DRUG" }, { "name": "Positron Emission Tomography (PET)", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Thomas Hope", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": null, "sex": "ALL", "summary": "3 Years and older" }, "enrollment_count": 143, "start_date": "2018-10-29", "completion_date": "2024-03-31", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-07-23T21:01:26.393Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04044937" } ] }